Outbreak of ciprofloxacin-susceptible community-associated meticillin-resistant Staphylococcus aureus in a neonatal unit.
Seetulsingh
P
P
Curtis
C
C
Kearns
A M
AM
D000890:Anti-Infective Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology*; D004196:Disease Outbreaks / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D006801:Humans; D007231:Infant, Newborn; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D007363:Intensive Care Units, Neonatal; D008131:London / Q000453:epidemiology; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D012867:Skin / Q000382:microbiology; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000635:transmission*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification
D000890:Anti-Infective Agents; D002939:Ciprofloxacin